Bioethics calls for papers / meetings & conferences

Call for Abstracts: International Society for Disease Surveillance Annual Conference

The ISDS Annual Conference is the premier event dedicated to the advancement of the science and practice of biosurveillance. This year’s theme, Expanding Collaborations to Chart a New Course in Public Health Surveillance, will highlight the importance of working together across agencies, sectors, and disciplines to improve surveillance methods and population health outcomes. The conference will be held at the Sheraton San Diego Hotel and Marina in San Diego, CA, December 4-5, 2012, with Pre-Conference Workshops on December 3rd.

The ISDS Conference draws professionals from a broad range of disciplines— epidemiology and computer science to mathematical modeling and health policy—to learn and contribute the latest achievements, methodologies, best practices, conceptual frameworks, and technical innovations in the rapidly evolving field of biosurveillance. This year's conference will provide fertile ground for cultivating new ideas and partnerships with roundtable discussions, panels and other opportunities to collaborate.

The scope of this conference includes all of the components, policies, methods, practices, infrastructure, research and evaluation related to timely surveillance of communicable diseases, chronic diseases and injuries. This includes notifiable conditions, adverse events and emerging/novel threats; biological, chemical, and radiological health threats; plant, animal, and food surveillance; and environmental monitoring.

Questions regarding the Call for Abstracts may be sent to Tera Reynolds, ISDS Program Manager.

Submission deadline: September 6, 2012 (11:59pm Eastern Daylight Time)

Authors notified of acceptance: October 3, 2012

Pre-Conference Workshops: December 3, 2012

Annual Conference: December 4-5, 2012

Submission Types

Note: All abstracts for the ISDS Conference will be submitted using ScholarOne. There is a limit of 4810 characters for the text of your submission. The character count includes spaces. The character count WILL include title, authors, institutions, tables, and images, but WILL NOT include presenting author brief biographical summaries (bios) or the abstract summary that will be used in the conference program.

Oral

All abstracts submitted for oral presentation are automatically considered for poster presentation as well. Include the following components when submitting an abstract for oral presentation:

· Title (85 characters MAX)

· Objective

· Introduction

· Methods

· Results

· Conclusions

· Acknowledgements

· References

· Names and affiliations of authors

· Brief bio of lead author/intended presenter (450 characters/75 words)

· Brief summary (600 characters/100 words) of submission to be used in conference program

Poster

Include the following components when submitting an abstract for poster presentation:

· Title (85 characters MAX)

· Objective

· Introduction

· Methods

· Results

· Conclusions

· Acknowledgements

· References

· Names and affiliations of authors

· Brief bio of lead author/intended presenter (450 characters/75 words)

· Brief summary (600 characters/100 words) of submission (for potential inclusion in conference program)

Panel *New for 2012*

Panel topics should be a specific aspect of design, theory, application, or experience pertaining to the science or practice of biosurveillance. Suggested panels should be comprised of no more than four participants and a moderator. A typical panel session will consist of four 15 minute presentations, each followed by 5 minutes of questions, with 10 minutes for closing discussion (presentation lengths will be subject to change based on final agenda). When submitting an abstract for a panel, include the following components:

· Title (85 characters MAX)

· Objective

· Introduction

· Panel description

· How the moderator intends to engage the audience in discussions on the panel topic

· Names of panel presenters, moderator and affiliations

· Brief bios for each panel presenter and moderator (450 characters/75 words each) for abstract reviewers to assess appropriateness to serve on the panel for the described topic

· Brief summary (600 characters/100 words) of panel to be used in conference program

Roundtable *New for 2012*

Roundtables can have up to three facilitators to briefly introduce the topic of interest and facilitate active discussion among attendees. Roundtables must be discussion-oriented rather than didactic, lecture-driven sessions. Roundtable discussions will be 60-90 minutes (depending on final agenda). When submitting an abstract for a roundtable, include the following components:

· Title (85 characters MAX)

· Objective

· Introduction

· Roundtable description

· How the facilitator intends to engage the audience in the roundtable discussion, including sample questions

· Names of facilitators and affiliations

· Brief bios for each facilitator (450 characters/75 words each) for abstract reviewers to assess appropriateness to lead a discussion on the described topic

· Brief summary (600 characters/100 words) of roundtable to be used in conference program

System Showcase Demonstrations *New for 2012*

System showcase demonstrations will be presented during the evening poster session on the first day of the conference. A typical demonstration will illustrate one or more aspects of an innovative population/public health surveillance system that is in use or under development. Demonstrations of open source and/or free products are strongly encouraged. System showcase demonstrations are not intended to be marketing or sales presentations and such submissions will be rejected; those interested in supporting the ISDS conference with an exhibit booth should contact Tera Reynolds at ISDS for more information. When submitting an abstract for a system showcase demonstration, include the following components:

· Title (85 characters MAX)

· Objective

· Introduction

· Description, highlighting benefits to public/population health surveillance and how this demonstration will be a unique addition to the ISDS conference

· Conclusions, including lessons learned and design principles from this demonstration that attendees can take away, even if not using or intending to use the system demonstrated

· Names of demonstrators and affiliations

· Brief summary (600 characters/100 words) of showcase to be used in conference program

Track Descriptions

I. Analytical Methods

a. Analytical Methods: Applied

b. Analytical Methods: Research & Development

This theme is focused on important and novel advances in the field of surveillance methodologies and analytical approaches. Abstracts in the Applied sub-track should describe methods or processes routinely used in a production-type environment. Abstracts in the Research and Development sub-track should describe methods and processes still under development or tested within a research or pilot setting. Possible topics include, but are not limited to:

· Analytic evaluation of surveillance components

· Decision support

· Estimating morbidity and impact

· Evaluation of algorithms and systems through epidemic simulation

· Geospatial analysis

· Innovative use of Geographic Information Systems (GIS) technology

· Integrating evidence from multiple sources

· Integration of mathematical modeling and statistical analyses

· New algorithms and evaluation of existing algorithms for cluster and event detection

· Pattern recognition algorithms

· Predictive disease modeling/predictive analytics

· Spatial cluster detection

· Statistical methods and tools for analyzing and interpreting data

· Time series analysis

II. Informatics

a. Informatics: Applied

b. Informatics: Research & Development

Abstracts in the Applied sub-track should describe methods or processes routinely used in a production-type environment. Abstracts in the Research and Development sub-track should describe methods and processes still under development or tested within a research or pilot setting. Possible topics include, but are not limited to:

· Advances in methods for classifying data

· Approaches to building interoperable surveillance systems and components

· Borderless data exchange models (e.g. federated information sharing approaches)

· Cloud computing for public health surveillance

· Data integration – acquiring, moving, storing, processing, coding, normalizing, and preparing data for analysis between systems

· Data quality

· Data visualization methods

· Electronic health records and public health surveillance

· Health information exchange

· How clinical information systems can support public health surveillance efforts

· How public health information systems can support clinical efforts

· Informatics lessons learned

· Information and knowledge exchange

· Innovations in public health informatics

· Mobile technologies for public health

· Natural language processing

· Standards and Interoperability Framework (Public Health Reporting Initiative)

· Standards used in public health surveillance

· System architectures for limited connectivity environments and disaster surveillance

· System architectures for surveillance in low-resource environments

· System architectures to leverage HIE for public health surveillance

· System descriptions of real-world solutions to challenging integration problems

· Workforce requirements and training

· Use of social media for biosurveillance

III. Policy (at local, state, federal, international levels)

This theme is focused on sharing successes, challenges or approaches leveraged in the use or development of policy which affects biosurveillance operations and activities. Possible topics include, but are not limited to:

· Creating successful surveillance partnerships

· Data sharing policies

· Federal policy agendas

· Funding strategies for surveillance

· How public health surveillance data have been used to inform policy

· International Health Regulations

· Legal/ethical/security/privacy issues in surveillance

· Meaningful Use responses by public health departments

· Policies around social media/leveraging social networks for risk communication, etc.

· Research collaborations to expand evidence-based health policy

· Workforce

IV. Public/Population health surveillance

a. Public/Population Health Surveillance: Practice

b. Public/Population Health Surveillance: Research

c. Public/Population Health Surveillance: Evaluation

This theme is focused on improving the daily processes of timely public/population health surveillance, including detection, signal validation, event characterization, investigation, and response. Abstracts in the Practice sub-track should describe practices routinely used in a production environment and/or deployed in field by public health departments or other agencies. Abstracts in the Research sub-track should describe research related to surveillance, health systems, etc. Abstracts in the Evaluation sub-track should describe evaluations of public/population health surveillance systems, workflows, protocols, etc. Possible topics include, but are not limited to:

· Adverse drug events and pharmacovigilance

· Case studies

· Chronic disease surveillance

· Collaboration success stories

· Contact tracing and network analysis

· Disaster/event surveillance

· Disparities surveillance

· Evaluation of surveillance systems

· Infectious disease surveillance

· Influenza-like illness surveillance

· Injury surveillance

· Innovations in biosurveillance

· Integrating surveillance across multiple data sources

· Integrating surveillance systems, e.g. syndromic and reportable diseases

· Linking response with frontline health workers

· Meaningful Use and how it’s changing/not changing surveillance practice

· Measuring vaccine efficacy, coverage, etc.

· Messaging/risk communication (what to say to the public, politicians and media about syndromic systems alerts)

· Mobile technologies for public health

· Novel approaches to communicable diseases surveillance and reporting (e.g., notifiable conditions, MRSA, nosocomial infections)

· OneHealth

· Outbreak detection, characterization and outbreak management

· School and university surveillance

· Situational awareness

· Social media and surveillance

· Surveillance across borders

· Surveillance for refugees and recent immigrants

· Surveillance in resource-limited settings

· Surveillance using ambulatory care data

· Surveillance using inpatient data

· Vaccine-preventable disease surveillance

Call for Abstracts: American Society of Human Genetics 62nd Annual Meeting

Tuesday, November 6 through Saturday, November 10, 2012 San Francisco, California

The receipt deadline for new abstract submission is June 4, 2012 at 8:00 pm (US EDT).

The world's top scientists and clinicians in the human genetics field will gather to present their latest research findings at the 62nd Annual Meeting of the American Society of Human Genetics (ASHG), which will be held on November 6-10, 2012, in San Francisco, CA (http://www.ashg.org/2012meeting). ASHG is the primary professional membership organization for human genetics specialists worldwide, representing nearly 8,000 researchers, academicians, clinicians, genetic counselors, nurses, and others with a special interest in this area (http://www.ashg.org).

The ASHG Annual Meeting continues to be the largest human genetics meeting in the world, attracting more than 7,000 scientific participants each year. The ASHG 2012 Meeting will provide attendees with the latest information about cutting-edge developments in human genetics and genomics research. In addition, nearly 250 U.S. and international exhibitors at this year's ASHG Exhibitor Trade Show will offer an unprecedented opportunity to view the latest advances in genetics-related products and services derived, in part, from work presented at previous ASHG meetings.

Topics to be addressed in the scientific program for the ASHG 2012 Meeting will include: gene discovery in human genetics; new insights and challenges from next generation sequencing; advances in medical genetics and translation/applications in clinical care; progress in gene therapy; personalized medicine; cancer genetics; advances in non-invasive prenatal diagnosis; revelations about human alleles from studies of model organisms; implications of population genetic studies; modeling in statistical genetics; data centralization and its implications for our field; ethical, legal and social implications of genomics; changes in genetics education; and much more.

For more information about the ASHG 2012 Annual Meeting, or to register and/or submit an abstract for presentation at this year’s meeting, please go to: http://www.ashg.org/2012meeting.

Call for Abstracts: Markers in Cancer 2012

October 11-13, 2012 Holywood, Florida

Deadline for submission: June 19, 2012, by 11:59 PM (EDT)

Abstracts must be submitted online using the official Markers in Cancer 2012 Abstract Submitter. E-mails and word processing files submitted outside this program will not be accepted. Each First Author will receive an e-mail to verify the abstract has been received.

Markers in Cancer 2012 (formerly known as the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer) will stimulate discussion on the use of biomarkers as a tool for optimizing detection and treatment in oncology.

Designed for clinicians, pathologists, clinical and translational researchers, statisticians, radiologists, and others who specialize in molecular diagnostics, the meeting will present the latest advances in cancer markers to assess drug efficacy, improve prognostic and predictive evaluations and imaging, and enhance clinical trial development.

This year's Meeting will focus on practice-oriented translational research. Join us in Florida to review and explore the latest innovations in cancer markers.

Authors must select one topic category that best fits the subject of their abstract. The Markers in Cancer Scientific Committee reserves the right to recategorize an abstract.

Clinical Evaluation of Biomarkers, including:
- Biomarker Readiness for Clinical Application
- Assay Validation
- Clinical Qualification
Imaging Biomarkers
Immune System and Immunotherapeutic Markers
Mechanism-based Markers of Resistance and Toxicity
Blood-based Markers, including:
- Circulating Tumor Cells/Cancer Stem Cells
- Plasma DNA
- Proteomics
Cell Signaling Pathways
Genetics, Genomics, Epigenetics, and Gene Expression, including:
- Bioinformatics in Biomarker Research
- Early Translation of Multi-Dimensional Markers
Regulatory Science, Policy, and Knowledge Transfer, including:
- Implementation Science
- Ethics
- IDE and Companion In Vitro Diagnostics
- Regulatory and Policy Considerations, Especially Cross-National
Other

Call for Papers: American Academy of Cosmetic Surgery 2013 Annual Meeting

AACS 29th Annual Scientific Meeting January 16-19, 2013 Las Vegas, Nevada

For over 25 years, the Academy remains the leader in quality, cutting-edge education for medical professionals worldwide in all areas of cosmetic surgery. Submit your paper to present at the 2013 Annual Meeting — the following types of papers are requested:

Basic Science
Clinical Trials
Technique
Ethics
Practice Management
Posters

Peer Review Disclosure
All papers regardless of categories shall be ranked by Peer Review on a 1 -5 scale. The rankings will be based on originality, scientific content, relevance of new information, study of methodology and commercial bias.

Call for Papers Submission Deadline: May 31

For questions regarding the Call for Papers submission process, contact Amanda Diana, Education Coordinator, at adiana@cosmeticsurgery.org or 312.981.6779.

Call for Abstracts: International Neuroethics Society 2012 Annual Meeting

The International Neuroethics Society is pleased to announce that the 2012 Annual Meeting will take place on October 11 and 12 in New Orleans as a satellite of the Society for Neuroscience meeting.

Abstracts should be up to 500 words (including title, author names and affiliations and references if applicable). At least one author must be an INS member and register for the Annual Meeting. Abstracts will be reviewed by the INS Program Committee. Work presented in abstracts must be in compliance with local IRB governance and comply with INS the Abstract Submission and Disclosure Statement at www.neuroethicssociety.org

Abstracts should be up to 500 words (including title, author names and affiliations and references if applicable). At least one author must be an INS member and register for the Annual Meeting. Abstracts will be reviewed by the INS Program Committee. Work presented in abstracts must be in compliance with local IRB governance and comply with INS the Abstract Submission and Disclosure Statement at www.neuroethicssociety.org

Five submissions will be selected for Oral Presentations. Two submissions will receive a $250 Travel Award. Twenty-five abstracts will be published in the online version of AJOB- Neuroscience.

FORMAT your abstract as follows: (1) All text left justified; (2) Title in capitals; (3) Authors' initials and surnames, with superscripts for institutional affiliations if more than one; (4) General question or issue being addressed should be stated at outset; (5) References optional and no more than 5, formatted for AJOB-N.

The deadline is 5:00 p.m. EDT on JULY 2, 2012. Submit your abstract to administrator@neuroethicssociety.org.

Presenting authors will receive notification about submission by August 1.

POSTER SPECIFICATIONS: When preparing your poster for the meeting, please keep the dimensions within 4 ft x 4 ft or 1.1 m x 1.1 m. The title should be large enough to read from several yards away. Other suggestions: include figures if applicable, use bulleted points as much as possible and avoid long sections of text.

The International Neuroethics Society is an interdisciplinary group of scholars, scientists, clinicians and other professionals who share an interest in the social, legal, ethical and policy implications of advances in neuroscience. Our mission is to promote the development and responsible application of neuroscience through interdisciplinary and international research, education, outreach and public engagement for the benefit of people of all nations, ethnicities, and cultures.

Call for Papers: German Science in Southern Europe, 1933-45

October 11-13, 2012 Lisbon, Portugal

Submissions deadline: June 15, 2012

The European fascist period is certainly a time of exclusions, disruptions, and confrontations, but it is also a time of network building and scientific and cultural exchange: the exhibitions, public lectures, academic or even touristic exchange that Germany organizes between 1933 and 1945 in the southern European countries (from Portugal to Romania, not forgetting Spain, Italy or Greece) reflect a hybrid (i.e. political and scientific) concern to be "recognized and imitated" (to put it in the words of the Hamburger romanist and NSDAP member Wilhelm Giese).

The conference welcomes paper proposals from a broad range of disciplines. Questions that could be addressed, especially on case studies examples, might
include, but are not limited to:

a.. Knowledge & Technology transfer
b.. Circulation and appropriation of Knowledge
c.. Fascism, Science, Culture
d.. Fascist Scientific Policies
e.. Science and the Economics of War
f.. Networks: Actors, Institutions, Events, Disciplines
g.. Academics: Exchange and Exile
h.. Influence, Persuasion, Coercion: Science, Culture and the 'Weltanschauungskrieg'
i.. Crossing Borders: the Role of Science and Culture in the Internationalization of Fascism

The Conference is hosted by the Faculty of Social and Human Sciences, New University of Lisbon, and organized by the Research project The Power of Science; German Science in Portugal, 1933-45.

A selection of papers presented at the Conference will be published in a book.

Graduate and Postgraduate students are strongly encouraged to submit papers on research in-progress or recently completed studies.

Working language of the conference: English (a limited number of papers presented in Portuguese, Spanish or German may also be accepted)

Submission of Abstracts: Please submit a paper abstract (300 words) and a short CV at http://pos.fcsh.unl.pt/conference

Submissions deadline: June 15, 2012

Notification of Acceptance: June 30, 2012

Further Information:

Please address all inquiries to pos.conference@gmail.com

Fernando Clara
Universidade Nova de Lisboa
Av. de Berna 26-C
P 1069-061 Lisboa
PORTUGAL
Telf.: +351 217 908 300-Ext.1295
Fax: +351 217 908 308
email: f.clara@fcsh.unl.pt

Call for Research: Seventh International Congress on Peer Review and Biomedical Publication

The primary aims of biomedical peer review are to select and improve research and other academic work for funding and publication by identifying and reducing bias and increasing the validity, quality, credibility, and worth of scientific reports. This remains a difficult balance.1​ Widespread advances in technology and communications have improved the speed, efficiency, and reach of scientific publication and have transformed the ways scientists, authors, reviewers, editors, clinicians, and the public interact with information and with each other. But these same advances also threaten the very nature of peer review and scientific publication. The need to critically evaluate the purpose, foundations, developments, and future prospects of this entire enterprise—from research proposal through and beyond publication—has never been stronger.

Since the first announcement in 1986, we have held 6 Peer Review Congresses at 4-year intervals with the aim of placing peer review and scientific publication under the same evaluation that science undergoes. The success of these congresses is clear from the stimulus they have given to new research into the processes whereby scientific work is funded, presented, and disseminated, peer reviewed, edited, published, enhanced, accessed, and used by others to change practice, influence funding and policy decisions, inspire discourse and debate, and stimulate new research.2,3​,4,5​,6,7​,8,9​ This progress has been measured both in increase in the number of abstracts submitted to each congress (from 50 for the first to more than 200 each for the last 2) and in MEDLINE citations to peer review research (from 109 in 1994 to 382 in 2010).

We now announce the Seventh International Congress on Peer Review and Biomedical Publication to be held in Chicago, Illinois, September 8-10, 2013. This congress, organized by JAMA and the BMJ, will feature 3 days of presentations of original research. As with the previous congresses, the aims of the 2013 congress are to improve the quality and credibility of peer review and selection processes used by journals and funders and to help advance the quality, efficiency, effectiveness, and equity of biomedical publication and the dissemination of scientific information throughout the world. As before, we urge scientists, editors, publishers, funders, readers, and all who are interested in the processes by which science is funded and published to get going on their research.

In addition to the topics traditionally addressed during the Peer Review Congresses, such as the effects of peer review and editorial processes on the quality of scientific reporting,10 abstracts summarizing original, high-quality research on any aspect of scientific peer review, publication, and information exchange are welcome. We also are eager to see new research on the technologic advances and innovations that continue to influence all aspects of biomedical publication and the dissemination of scientific information. The increasing sophistication of research into these issues means that preference will be given to well-developed studies with generalizable results (eg, multijournal, prospective, multiyear trials and controlled studies). Retrospective studies, systematic reviews, bibliometric and other data analyses, surveys, and other types of studies will also be considered. Abstracts that report new research and findings will be given priority.

Topics of Interest for the Seventh International Congress on Peer Review and Biomedical Publication

Existence of every sort of bias and efforts to eliminate biased reporting

Editorial and peer review decision making and responsibilities

Mechanisms of peer review and editorial decision making usedby journals and funders

Evaluations of the quality, validity, and practicality of peer review and editorial decision making

Quality assurance for reviewers and editors

Editorial policies and responsibilities

Editorial freedom and integrity

Peer review of grant proposals

Research and publication ethics

Ethical concerns for researchers, authors, reviewers, editors, publishers, and funders

Authorship, contributorship, and responsibility for published material

Conflicts of interest

Research and publication misconduct

Confidentiality

Effects of funding and sponsorship on research and publication

Influence of external stakeholders: funders, journal owners, advertisers/sponsors, policy makers, legal representatives, and the news media

Evaluations of and mechanisms for improving the quality of reporting

Effectiveness of guidelines and standards designed to improve the quality of scientific publication

Evaluations of the quality of print and online information

Quality and reliability of data presentation and scientific images

Quality and use of online supplemental content

Quality and effectiveness of new forms of scientific articles

Models for peer review and scientific publication

Online publication

Open access

Open peer review

Data sharing and access

Prepublication posting and release of information

Postpublication review, communications, and influence

Changes in readership and usage of peer-reviewed published content

Presentation, enhancement, and quality of scientific information in multimedia and new media

Quality, use, and effects of publication metrics and usage statistics

Quality and influence of sponsored supplements and related media, gray literature, and other forms of publication

Quality and effectiveness of content tagging, markup, and structures

The future of scientific publication

Dissemination of scientific and scholarly information

Methods for improving the quality, efficiency, and equitable distribution of biomedical information

New technologies that affect the quality, integrity, dissemination, and access of biomedical information

The impact of social networking and new media on science critique and dissemination

REFERENCES

1. Lock S. A Difficult Balance: Editorial Peer Review in Medicine. London, UK: Nuffield Provincial Hospitals Trust; 1985.

2. Rennie D. Guarding the guardians: a conference on editorial peer review. JAMA. 1986;256(17):2391–2392, pmid:3773144.Free Full Text

3. Guarding the guardians: research on editorial peer review; selected proceedings from the First International Congress on Peer Review in Biomedical Publication. May 10-12, 1989, Chicago, Ill. JAMA. 1990;263(10):1317–1441, pmid:2304208.

4. Rennie D, Flanagin A. The Second International Congress on Peer Review in Biomedical Publication. JAMA. 1994;272(2):91, pmid:8015138.

5. Third International Congress on Peer Review and Biomedical Publication. JAMA. 1998;280(3, theme issue):203–306.

6. Fourth International Congress on Peer Review and Biomedical Publication. JAMA. 2002;287(21, theme issue):2759–2871.

7. Rennie D, Flanagin A, Smith R, Smith J. Fifth International Congress on Peer Review and Biomedical Publication: call for research. JAMA. 2003;289(11):1438.

8. Rennie D, Flanagin A, Godlee F, Smith J. Sixth International Congress on Peer Review and Biomedical Publication, September 2009: call for research. JAMA. 2007;298(20):2420–2421.

9. Seventh International Congress on Peer Review and Biomedical Publication. http://www.ama-assn.org/public/peer/peerhome.htm. Accessed January 25, 2012.

10. Jefferson T, Rudin M, Brodney Folse S, Davidoff F. Editorial peer review for improving the quality of reports of biomedical studies. Cochrane Database Syst Rev. 2007;(2):MR000016, doi:10.1002/14651858.MR000016.pub3, pmid:17443635.Medline

Call for Abstracts: International Symposium on Ocular Pharmacology and Therapeutics ISOPT Clinical 2013

March 7-10, 2013 Paris, France

The deadline for the submission of abstracts: December 4th, 2012.

Abstracts submitted after this deadline may be considered for presentation, but will not be included in the program book.

ISOPT will reconvene in Paris March 7 – 10 for our 10th symposium. Over the years, ISOPT has repeatedly shaped its form so it can accommodate to provide a collaborative atmosphere for clinicians, clinical trialists, pharma industry and regulatory officers. Our formed vision has been to increase knowledge and awareness of drug usage in ophthalmology reflecting innovations and their utilization in practice. In order to achieve this vision ISOPT is set to implement the following missions:

Educate via updating and sharing current and evolving treatment algorithms for practitioners.

Connect data arising from clinical studies to actual daily practice.

Facilitate innovation via panels and discussions of early and late “development related topics”.

We invite you to join us in Paris, and become a part of ISOPT, bring your own experience and insights of treating your patients, be exposed to the last two year clinical experience gained in major industry supported studies and be part of the efforts to reflect scientific data to clinical reality and patient care.

ISOPT has become famous for its informal atmosphere and the ability to meet experts and faculty leaders for “out of the lecture hall” discussions.

Whether your field of interest is in retinal diseases, inflammation, cornea and external diseases, glaucoma or basic science you may contribute and be part of the ISOPT spirit.